Compounds > dextroamphetamine
Page last updated: 2024-08-17

dextroamphetamine and am-356

dextroamphetamine has been researched along with am-356 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goutopoulos, A; Järbe, TU; Lamb, RJ; Lin, S; Makriyannis, A1
Järbe, TU; Lamb, RJ; Liu, Q; Makriyannis, A1

Other Studies

2 other study(ies) available for dextroamphetamine and am-356

ArticleYear
Effects of Delta 9-tetrahydrocannabinol, (R)-methanandamide, SR 141716,and d-amphetamine before and during daily Delta 9-tetrahydrocannabinol dosing.
    European journal of pharmacology, 2000, Jun-16, Volume: 398, Issue:2

    Topics: Animals; Arachidonic Acids; Behavior, Animal; Conditioning, Operant; Dextroamphetamine; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Drug Tolerance; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Time Factors

2000
Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Delta9-THC or (R)-methanandamide (AM-356).
    Psychopharmacology, 2006, Volume: 188, Issue:3

    Topics: Analysis of Variance; Animals; Arachidonic Acids; Dextroamphetamine; Discrimination Learning; Dose-Response Relationship, Drug; Dronabinol; Hallucinogens; Injections, Intraperitoneal; Male; Morphine; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Regression Analysis; Reinforcement Schedule; Rimonabant; Time Factors

2006